share_log

HC Wainwright & Co. Maintains Buy on Can Fite Biofarma, Lowers Price Target to $18

HC Wainwright & Co. Maintains Buy on Can Fite Biofarma, Lowers Price Target to $18

HC Wainwright & Co.維持對 Can Fite Biofarma 的買入,將目標價下調至18美元
Benzinga ·  2023/10/24 19:09

HC Wainwright & Co. analyst Vernon Bernardino maintains Can Fite Biofarma (AMEX:CANF) with a Buy and lowers the price target from $34 to $18.

HC Wainwright & Co. 分析師弗農·貝納迪諾將Can Fite Biofarma(AMEX: CANF)維持買入,並將目標股價從34美元下調至18美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論